You are visiting a Controlled Access Programme (CAP) portal designed to meet European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) requirements
This site contains important safety information for UK based Healthcare Professionals who may wish to prescribe Finteplaâ–¼ (fenfluramine) in the United Kingdom
Educational material for patients can also be accessed here
Please select the appropriate box below to continue